Role of FGF19 induced FGFR4 activation in the regulation of glucose homeostasis

被引:25
|
作者
Wu, Xinle [1 ]
Li, Yang [1 ]
机构
[1] Amgen Inc, 1120 Vet Blvd, San Francisco, CA 94080 USA
来源
AGING-US | 2009年 / 1卷 / 12期
关键词
fibroblast growth factors; FGF19; FGF21; FGF23; aging; diabetes; metabolic diseases; insulin; METABOLIC-ACTIVITY; BETA-KLOTHO; GROWTH; SPECIFICITY; SUPPRESSION; DETERMINES; EXPRESSION; SIGNAL; FAMILY; MODE;
D O I
10.18632/aging.100108
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
FGF19, FGF21, and FGF23 form a unique subfamily of fibroblast growth factors. Because they contain intra molecular disulfide bonds and show reduced affinity toward heparan sulfate located in the extracellular space, it is thought that, in contrast to other FGFs, they function as endocrine hormones. FGF23 and its co-receptor alpha Klotho are involved in the control of aging, but it is not known if the same holds true for FGF19, which can also signal through alpha Klotho. However, considerable evidence supports a role for FGF19 in controlling various aspects of metabolism. We have recently fully characterized FGF19/FGFR/co-factor interactions and signaling, and in the current manuscript discuss the contribution of the FGF19/FGFR4 axis to bile acid and glucose regulation.
引用
收藏
页码:1023 / 1027
页数:5
相关论文
共 50 条
  • [1] Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice
    Wu, Xinle
    Ge, Hongfei
    Lemon, Bryan
    Weiszmann, Jennifer
    Gupte, Jamila
    Hawkins, Nessa
    Li, Xiaofan
    Tang, Jie
    Lindberg, Richard
    Li, Yang
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (34) : 14379 - 14384
  • [2] Expression of FGF19/FGFR4 related biomarkers in hepatocellular carcinoma
    Lin, Zhong-Zhe
    Jeng, Yung -Ming
    Hsu, Chiun
    Tsai, I-Lun
    Chen, Kuan-Yu
    Hu, Fu -Chang
    Hsu, Chih-Hung
    Hsu, Hey-Chi
    Cheng, Ann-Lii
    CANCER RESEARCH, 2016, 76
  • [3] Making way for suppressing the FGF19/FGFR4 axis in cancer
    Prieto-Dominguez, Nestor
    Shull, Austin Y.
    Teng, Yong
    FUTURE MEDICINAL CHEMISTRY, 2018, 10 (20) : 2457 - 2469
  • [4] FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib
    Lixia Gao
    Xuli Wang
    Yaoliang Tang
    Shuang Huang
    Chien-An Andy Hu
    Yong Teng
    Journal of Experimental & Clinical Cancer Research, 36
  • [5] FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib
    Gao, Lixia
    Wang, Xuli
    Tang, Yaoliang
    Huang, Shuang
    Hu, Chien-An Andy
    Teng, Yong
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 36
  • [6] Differential Specificity of Endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in Complex with KLB
    Yang, Chaofeng
    Jin, Chengliu
    Li, Xiaokun
    Wang, Fen
    McKeehan, Wallace L.
    Luo, Yongde
    PLOS ONE, 2012, 7 (03):
  • [7] FGF19 immunostaining as biomarker for trial enrichment testing FGFR4 inhibitors in HCC
    Moeini, Agrin
    Hoeflich, Klaus
    Pinyol, Roser
    Sia, Daniela
    Miduturu, Chandra
    Montal, Robert
    Peix, Judit
    Comprecios, Genis
    Cao, Qiongfang
    Stransky, Nicolas
    Schmidt-Kittler, Oleg
    Miller, Stephen
    Thung, Swan N.
    Lengauer, Christoph
    Llovet, Josep M.
    HEPATOLOGY, 2016, 64 : 622A - 623A
  • [8] Salvianolic acid B blocks hepatic stellate cell activation via FGF19/FGFR4 signaling
    Tian, Shuxia
    Chen, Min
    Wang, Bing
    Han, Yonglong
    Shang, Haonan
    Chen, Junming
    ANNALS OF HEPATOLOGY, 2021, 20
  • [9] FGF19-induced Hepatocyte Proliferation Is Mediated through FGFR4 Activation
    Wu, Xinle
    Ge, Hongfei
    Lemon, Bryan
    Vonderfecht, Steven
    Weiszmann, Jennifer
    Hecht, Randy
    Gupte, Jamila
    Hager, Todd
    Wang, Zhulun
    Lindberg, Richard
    Li, Yang
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (08) : 5165 - 5170
  • [10] Alteration in the serum concentrations of FGF19, FGFR4 and βKlotho in patients with thyroid cancer
    Motylewska, Ewelina
    Stepien, Tomasz
    Borkowska, Magdalena
    Kuzdak, Krzysztof
    Siejka, Agnieszka
    Komorowski, Jan
    Stepien, Henryk
    Lawnick, Hanna
    CYTOKINE, 2018, 105 : 32 - 36